Dear Esteemed Medical Professionals, Industry Leaders, and Academic Colleagues,
Welcome to the official website of the 30th Annual Taiwan Joint Cancer Conference (TJCC 2026)!
As we approach the 30th anniversary of this landmark event in 2026, we mark not only a significant historical milestone but also a pivotal new beginning. This year's theme—"Beyond Limits: Toward a Next Era in Cancer Medicine"—reflects our shared commitment to continuous innovation and clinical excellence in oncology.
Over the past three decades, the Taiwan Joint Cancer Conference has remained steadfast in its mission to foster cross-disciplinary integration and forward-looking innovation. By uniting professional societies, healthcare institutions, research centers, and the biopharma industry—both domestically and internationally—the conference has become a vital platform for collaboration in cancer prevention, precision medicine, and evidence-based clinical practice.
For this special edition, we have created a more expansive and in-depth program that brings together diverse dimensions of academic research, clinical application, industry development, and health policy. Highlights of the conference will include:
- Cutting-edge treatment strategies and updated clinical guidelines across major cancer types
- Practical applications of precision oncology, immunotherapies, and biomarker-driven therapies
- Dedicated forums for nurturing the next generation of physician-scientists and early-career researchers
- International keynote lectures and satellite symposia
- Industry exhibitions and opportunities for interdisciplinary academic-industry collaboration
We sincerely invite you to participate in this landmark event—as an attendee, speaker, abstract presenter, or strategic partner. Your presence will be invaluable in shaping a conference that is both globally connected and locally grounded, and that champions innovation with depth and impact.
Let us come together to build a transformative gathering that not only advances cancer medicine but also enhances the well-being of our patients.
We look forward to welcoming you in person.
Wishing you good health and continued success,
Cheng-Chang (Curtis) CHANG, M.D., Ph.D.
President, Society of Gynecologic Oncology, Republic of China (Taiwan)
Chairperson, 30th Taiwan Joint Cancer Conference (TJCC 2026)